We first demonstrated the anticancer potential of eupatilin, which induced calcium-dependent apoptosis associated with disruption of the ER–mitochondrial axis by targeting SERPINB11 in ovarian cancer cell lines. This evidence concerns the gene SERPINB11 and ovarian carcinoma.